https://orcid.org/0000-0001-9173-9000
References
- WHO. Influenza (Seasonal). [accessed 2020 May 12]. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal) .
- WHO. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012;87:461–4.
- WHO. WHO recommendations on the composition of influenza virus vaccines. [ accessed 2020 May 12]. https://www.who.int/influenza/vaccines/virus/recommendations/en/ .
- Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG. The vaccine adverse event reporting system (VAERS). Vaccine. 1994;12:542–50. doi:10.1016/0264-410X(94)90315-8.
- Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13:265–76. doi:10.1586/14760584.2014.866895.
- Cashman P, Macartney K, Khandaker G, King C, Gold M, Durrheim DN. Participant-centred active surveillance of adverse events following immunisation: a narrative review. Int Health. 2017;9:164–76. doi:10.1093/inthealth/ihx019.
- Westphal DW, Williams SA, Leeb A, Effler PV. Continuous active surveillance of adverse events following immunisation using SMS technology. Vaccine. 2016;34:3350–55. doi:10.1016/j.vaccine.2016.05.015.
- Regan AK, Blyth CC, Mak DB, Richmond PC, Effler PV. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Aust N Z J Obstet Gynaecol. 2014;54:522–28. doi:10.1111/ajo.12266.
- Pillsbury A, Quinn H, Cashman P, Leeb A, Macartney K. Active SMS-based influenza vaccine safety surveillance in Australian children. Vaccine. 2017;35:7101–06. doi:10.1016/j.vaccine.2017.10.091.
- Pasteur S. Fluzone quadrivalent: influenza virus vaccine quadrivalent types A and B (split virion). Product Monograph. 2019 [accessed 2020 May 12]. http://products.sanofi.ca/en/fluzone-qiv.pdf .
- Secretaría de Salud. Ficha Technica Fluzone Quadrivalent. [accessed 2020 July 01 https://www.gob.mx/cms/uploads/attachment/file/243174/146M2014.pdf .
- Leeb A, Regan AK, Peters IJ, Leeb C, Leeb G, Effler PV. Using automated text messages to monitor adverse events following immunisation in general practice. Med J Aust. 2014;200:416–18. doi:10.5694/mja13.11166.
- Cashman P, Moberley S, Dalton C, Stephenson J, Elvidge E, Butler M, Durrheim DN. Vaxtracker: active on-line surveillance for adverse events following inactivated influenza vaccine in children. Vaccine. 2014;32:5503–08. doi:10.1016/j.vaccine.2014.07.061.
- Baron S, Goutard F, Nguon K, Tarantola A. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study. J Med Internet Res. 2013;15:e68. doi:10.2196/jmir.2477.
- Stockwell MS, Broder K, LaRussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. JAMA Pediatr. 2014;168:211–19. doi:10.1001/jamapediatrics.2013.4469.
- Secretaría de Salud. Manual de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización. [accessed 2020 May 12]. https://www.gob.mx/cms/uploads/attachment/file/287240/ESAVI_2014.pdf .
- Vidal P, Reyna J, Saldana P, Richardson VL. Events temporarily associated with anti-influenza A (H1N1) vaccination in Mexico. Arch Med Res. 2011;42:627–32. doi:10.1016/j.arcmed.2011.10.007.
- Secretaría de Salud. Eventos Temporalmente Asociados a Vacunación. Manual de Procedimientos Técnicos. [accessed 2020 May 12]. http://www.salud.gob.mx/unidades/cdi/documentos/manualetav.pdf .
- Lajous M, Danon L, Lopez-Ridaura R, Astley CM, Miller JC, Dowell SF, O’Hagan JJ, Goldstein E, Lipsitch M. Mobile messaging as surveillance tool during pandemic (H1N1) 2009, Mexico. Emerg Infect Dis. 2010;16:1488–89. doi:10.3201/eid1609.100671.
- Kuerbis A, van Stolk-cooke K, Muench F. An exploratory study of mobile messaging preferences by age: middle-aged and older adults compared to younger adults. J Rehabil Assist Technol Eng. 2017;4:2055668317733257. doi:10.1177/2055668317733257.